Cargando…
Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles
OBJECTIVE(S): BCG vaccine has no longer been appreciated to immunize against tuberculosis, worldwide, so novel appropriate adjuvants have been dedicated to improve immune responses. This study aimed to evaluate the immunomodulatory effects of ISCOMATRIX as an adjuvant to stimulate potent humoral and...
Autores principales: | Najafi, Adel, Ghazvini, Kiarash, Sankian, Mojtaba, Gholami, Leila, Zare, Sirwan, Yousefi Arvand, Arshid, Tafaghodi, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510487/ https://www.ncbi.nlm.nih.gov/pubmed/37736514 http://dx.doi.org/10.22038/IJBMS.2023.67564.14806 |
Ejemplares similares
-
Cloning, Expression, and Refolding of PPE17 Protein of Mycobacterium Tuberculosis as a Promising Vaccine Candidate
por: Najafi, Adel, et al.
Publicado: (2019) -
A novel nanomicelle composed from PEGylated TB di-peptide could be successfully used as a BCG booster
por: Firouzi, Zohreh, et al.
Publicado: (2022) -
Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration
por: Khademi, Farzad, et al.
Publicado: (2019) -
Modified genome comparison method: a new approach for identification of specific targets in molecular diagnostic tests using Mycobacterium tuberculosis complex as an example
por: Neshani, Alireza, et al.
Publicado: (2018) -
Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid
por: Moghadam Ariaee, Faezeh, et al.
Publicado: (2012)